Benjamine Liu is the CEO and Co-founder of Formation Bio, an AI-native pharma company focused on accelerating drug discovery and development. A Rhodes Scholar with a D.Phil. in Computational Biology from Oxford, he previously conducted research on neurodegenerative diseases and computational biomarkers. He also advises Harvard Business School’s MS/MBA Biotech Program and has been recognized in BioSpace’s 40 Under 40 Class of 2025.